IL1F10 and non-small cell lung carcinoma: In the latest clinical study conducted by Feng Wang et al., possible correlations between IL-38 and clinical outcomes of patients with non-small cell lung cancer (NSCLC) (including survival rate, cancer progression, and sensitization to chemotherapy) were investigated.